CELESSE LTD

Executive Summary

CELESSE LTD is a newly established micro-entity with no financial transactions recorded in its first year, reflecting a neutral but vulnerable financial state. To progress towards financial health, the company should focus on capital injection, operational commencement, and rigorous financial planning. Early action will build a healthy cash flow foundation and mitigate risks associated with start-up inactivity.

CELESSE LTD - Analysis Report

Company Number: 15161879

Analysis Date: 2025-07-20 19:13 UTC

Financial Health Assessment Report for CELESSE LTD
Assessment Date: June 2025
Financial Year End: 30 September 2024

---

1. Financial Health Score: Grade D

Explanation:
CELESSE LTD is a newly incorporated micro-entity with no recorded financial activity during its first financial year ending September 2024. The absence of assets, liabilities, revenue, or profit means the company is in a nascent stage with neither financial strength nor distress evident yet. This "zero balance sheet" represents a neutral but fragile financial state, warranting close monitoring as operations commence.

---

2. Key Vital Signs

Metric	Value	Interpretation
Fixed Assets	£0	No investment in long-term resources yet.
Current Assets	£0	No cash or receivables on hand.
Current Liabilities	£0	No short-term debts or payables outstanding.
Net Current Assets	£0	Neutral working capital position.
Net Assets (Equity)	£0	No equity capital or retained earnings.
Shareholders’ Funds	£0	No capital injected beyond nominal.
Number of Employees	1	Minimal staffing, low overhead.
Company Status	Active	Operating, but financial activity pending.
Company Category	Micro	Small scale, simplified reporting.
Industry Classification (SIC)	62012	Business and domestic software development.

---

3. Diagnosis: Initial Stage with No Financial Activity ("Dormant-like")

• The financial "vitals" show a flatline: no assets, no liabilities, no revenue, or expenses reported for the first year. This is typical for a company in its incubation phase before active trading begins.
• The absence of cash or working capital is a symptom of inactivity rather than distress at this stage.
• The single director and employee structure suggests a sole operator or founder-run venture.
• The company’s micro-entity status means it benefits from simplified filings but also indicates limited scale at the moment.
• The director holds significant control (50-75% shares and voting rights), indicating a closely held private enterprise.
• No signs of financial stress such as overdrafts, creditor pressure, or loss reserves are present, but also no signs of financial strength.
• The company must now focus on building healthy cash flow and capital injection to transition from this baseline to active operational status.

---

4. Recommendations for Improving Financial Wellness

• Capital Injection: Consider an initial equity or loan funding round to provide working capital for business activities, software development, and operational expenses. A healthy cash flow is critical to avoid future liquidity symptoms such as creditor pressure or insolvency risk.
• Financial Planning: Develop a detailed budget and cash flow forecast for the next 12 months to anticipate funding needs and monitor burn rate. This will help detect early symptoms of financial strain and allow corrective action.
• Operational Activity: Begin or ramp up trading activities to generate revenue. Even minimal sales will create financial signals of business viability and support future credit standing.
• Record-Keeping & Compliance: Maintain accurate financial records in anticipation of future filings. Even with micro-entity exemptions, transparency supports business credibility.
• Seek Professional Advice: Consider consulting financial advisors or accountants early to set up robust accounting systems and tax planning, minimizing risks.
• Monitor Key Metrics: Once trading starts, track liquidity ratios (current ratio), profitability margins, and debt levels regularly to maintain a healthy financial pulse.
• Explore Grants or Support: For software development, investigate government grants or innovation funding schemes to supplement capital.

---

Medical Analogy Summary:
CELESSE LTD currently resembles a patient in the "pre-symptomatic" stage—there are no signs of financial illness, but also no signs of vitality yet. Without the "nutrients" of working capital and revenue, the company risks stagnation. Early interventions focused on capital infusion and initiating operations will enable CELESSE LTD to develop a healthy financial pulse and avoid future distress.

---